Surprise Castle
New Trends in Cancer for the 21st Century

New Trends in Cancer for the 21st Century - Hardcover

$98.99
$99.00
Quantity
01

Pay over time for orders over $35.00 with

Offers & Perks

Earn 98 points with this purchase

Added to your rewards balance after checkout.

100 points welcome bonus

Create an account and start with extra points.

Join now
Languages:EnglishPublisher:SpringerISBN-13:9780306477621ISBN-10:0306477629UPC:9780306477621Book Category:Science, MedicalBook Subcategory:Life Sciences, Oncology, PharmacologyBook Topic:Genetics & GenomicsSize:9.21 x 6.14 x 0.75 inchesWeight:0.608Product ID:SC59YVHXHR
Driving the Cell Cycle to Cancer.- Proliferation: The Cell Cycle.- Molecular Analysis of Gene Expression in Tumor Pathology.- Ewing Tumor Biology: Perspectives for Innovative Treatment Approaches.- Cancer Epigenetics: DNA Methylation and Chromatin Alterations in Human Cancer.- Molecular Analysis of Cancer Using DNA and Protein Microarrays.- Proteomic Approaches to the Diagnosis, Treatment, and Monitoring of Cancer.- Structural Basis of Tumoral Angiogenesis.- Matrix Metalloproteinases and Tumor Progression.- Angiogenesis Inhibitors and Their Therapeutic Potentials.- Mutated Tyrosine Kinases as Therapeutic Targets in Myeloid Leukemias.- Targeting PDGF Receptors in Cancer-Rationales and Proof of Concept Clinical Trials.- Immune-Promoted Tumor Cell Invasion and Metastasis. New considerations in cancer therapy.- Improvements of Survival in Nine Phase II Clinical Studies With Different Types of Cancer Upon Anti-Tumor Vaccination with an Autologous Tumor Cell Vaccine Modified by Virus Infection to Introduce Danger Signals.- Causation and Prevention of Solely Estrogen-Induced Oncogenesis: Similarities to Human Ductal Breast Cancer.- Cyclooxygenase-2 Inhibitors in Cancer Prevention and Treatment.- Exosomes for Immunotherapy of Cancer.- Breast Cancer Gene Expression Analysis a The Case for Dynamic Profiling..- Development of the Epidermal Growth Factor Receptor Inhibitor TARCEVATm (OSI-774).- Gefitinib (TRESSA, ZD 1839) for Non-Small Cell Lung Cancer (NSCLC): Recents Results and Further Strategies.- Mechanism of Action of Anti-HER2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2C4.- EORTC Research and Development: Achievements and Future Perspectives.- Contributors.
Languages:EnglishPublisher:SpringerISBN-13:9780306477621ISBN-10:0306477629UPC:9780306477621Book Category:Science, MedicalBook Subcategory:Life Sciences, Oncology, PharmacologyBook Topic:Genetics & GenomicsSize:9.21 x 6.14 x 0.75 inchesWeight:0.608Product ID:SC59YVHXHR
Publisher: Springer

Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.